Skip to main content

Integrative Medicine

Over the past decade, there has been an increase in the use of integrative modalities for improving health and disease outcome. It is estimated that more than 40% of cancer patients use some form of complementary and alternative medicine, and/or integrative modalities for management of cancer-related symptoms and improvement of quality of life, and perhaps a perceived improved the outcome of standard treatment.  Improvement in sleep, reduction of fatigue, relief of pain, and a sense of well-being are among the most common cancer-related health needs that result in consultation from integrative services. The most common integrative modalities discussed are lifestyle interventions (such as diet, meditation and exercise) and natural products. Additional evidenced-based knowledge could broaden the scope of the discussion, paralleling the concerns of the patient.

As such, there is a need for continued objective and rigorous research into the elucidation of biological action, assessment of safety and effectiveness of various interventions or modalities, and provision of evidence-based information with solid scientific background for patients and practitioners of integrative oncology and general medicine.

This course is designed to provide an introduction and overview of the:

  1. Concept
  2. Evidence-based practice or usage, and
  3. Current state of research in integrative modalities or strategies.

The participation of NIH postdoctoral and clinical fellows is highly encouraged to help broaden their scope and depth of research knowledge in a growing field of medicine.

There is no registration fee for this course.


Participants who register for this course will receive a certificate of completion after attending the lectures and completing an online final examination.

  • Final Exam
  • Course Evaluation

Location and Time

The Integrative Medicine course will be held on Thursday afternoons (3:00 – 4:00 PM) on the Bethesda Campus (Bldg. 50, Room 1328). Exceptions to this location will be noted on the agenda. The lectures can also be viewed via WebEx live. There will be two visits to laboratory and clinical center.

Sessions will consist of a 50-minute lecture with ample time for discussion and analysis. A handout for each topic will be distributed on-site, day of the lecture.

Integrative Medicine Course (1) Schedule - Fall 2019
Date Lecture Faculty
Tuesday Oct. 8 Acupuncture Helene Langevin
Thursday Oct. 24 Dietary Supplement and Natural Product Barbara Sorkin
Thursday Nov. 7 Palliative Care Ann Berger
Thursday Nov. 21 Meditation and Mind-Body David Shurtleff
Thursday Dec. 5 Sleep Ashura Buckley
Thursday Dec. 12 Chronomedicine & Time-Restricted Feeding Dan Xi & Satchin Panda
Thursday Dec. 19 Discussion and Integrative Medicine Research Portfolio Faculties

Additional Information

Contact Dr. Terry Moody at and Dr. Dan Xi at

Faculty Coordinators

  • Ann Berger, M.D.
  • Terry Moody, Ph.D.
  • David Shurtleff, Ph.D.
  • Dan Xi, Ph.D.
  • Farah Zia, M.D.


  • Ann Berger, M.D.
  • Ashura Buckley, M.D.
  • Helene Langevin, M.D.
  • Terry Moody, Ph.D.
  • Satchidananda Panda, Ph.D.
  • David Shurtleff, Ph.D.
  • Barbara Sorkin, Ph.D.
  • Dan Xi, Ph.D.
  • Farah Zia, M.D.

Related Training Opportunities

This course is part of an ongoing training curriculum for NCI clinical and postdoctoral fellows. Each fall CCT offers the Translational Research in Clinical Oncology (TRACO) course, hosted by Dr. Terry Moody.

Another course, Demystifying Medicine, is held each spring. This course provides 2 hours of lecture each week (January – May) and is hosted by Dr. Irvin M. Arias.

NIH offers additional training opportunities.

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Integrative Medicine was originally published by the National Cancer Institute.”